Patent details

EP3746057 Title: DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE

  • Data
  • Documents

Basic Information

Publication number:
EP3746057
PCT Application Number:
US2019016012
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197466766
PCT Publication Number:
WO2019152627
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE
French Title of Invention:
DAPANSUTRILE POUR LA PRÉVENTION OU LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
German Title of Invention:
DAPANSUTRIL ZUR PRÄVENTION ODER BEHANDLUNG VON MORBUS ALZHEIMER
SPC Number:

Dates

Filing date:
31/01/2019
Grant date:
20/03/2024
EP Publication Date:
09/12/2020
PCT Publication Date:
08/08/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/03/2024
EP B1 Publication Date:
20/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
31/01/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/03/2024
 
 

Name:
Olatec Therapeutics, Inc.
Address:
800 Fifth Avenue, 25 Floor, New York, NY 10065, United States (US)

Inventor

Name:
DINARELLO, Charles A.
Address:
United States (US)

Priority

Priority Number:
201862624637 P
Priority Date:
31/01/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/10; A61K 31/275; A61P 25/28; A61K 9/00;

Publication

European Patent Bulletin

Issue number:
202412
Publication date:
20/03/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: